Outcome of Breast Cancer Patients with COVID-19 Infection: A Report from a Tertiary Cancer Center in India

Background: There is no data on the outcome of COVID-19 infection in patients with breast cancer from India. This study was done to assess the outcome of patients with breast cancer who had COVID-19 infection. Methods: We analyzed patients with breast cancer who were diagnosed with COVID-19 infec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Indhuja Muthiah Vaikundaraja, Manikandan Dhanushkodi, Venkatraman Radhakrishnan, Jayachandran Peumal Kalaiyarasi, Gangothri Selvarajan, Siva Sree Kesana, Carthikeyan SM, Priya Iyer, Balasubramanian Ananthi, Arvind Krishnamurthy, Sridevi Velusamy, Tenali Gnana Sagar
Formato: article
Lenguaje:EN
Publicado: Kaviani Breast Disease Institute 2021
Materias:
Acceso en línea:https://doaj.org/article/156670456bfc49909bb189f51ad1c0cd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:156670456bfc49909bb189f51ad1c0cd
record_format dspace
spelling oai:doaj.org-article:156670456bfc49909bb189f51ad1c0cd2021-12-04T02:18:55ZOutcome of Breast Cancer Patients with COVID-19 Infection: A Report from a Tertiary Cancer Center in India10.32768/abc.202184291-2962383-0433https://doaj.org/article/156670456bfc49909bb189f51ad1c0cd2021-10-01T00:00:00Zhttps://www.archbreastcancer.com/index.php/abc/article/view/421https://doaj.org/toc/2383-0433 Background: There is no data on the outcome of COVID-19 infection in patients with breast cancer from India. This study was done to assess the outcome of patients with breast cancer who had COVID-19 infection. Methods: We analyzed patients with breast cancer who were diagnosed with COVID-19 infection from May to September 2020 in the medical oncology department of a tertiary cancer center in India. Symptomatic patients (fever and influenza-like illness symptoms) or asymptomatic patients planned for systemic therapy were tested for COVID-19 by RT-PCR. Results: A total of 441 breast cancer patients received 1174 systemic therapies from May to September 2020. Among them, 36 patients who had COVID-19 infection were analyzed in detail. The majority (86%) were asymptomatic at presentation. The most common symptoms were fever followed by cough. Patients were either admitted to the hospital (53%) or kept in home quarantine (47%). Patients who received oxygen, non-invasive assisted ventilation (NIV), and mechanical ventilation (MV) were 8%, 3%, and 3% respectively. The median duration of hospitalization and home quarantine was 11 days and 19 days respectively. The recovery of patients with COVID-19 infection was 94%. The median duration to clearing SARS-COV-2 by RT-PCR was 19 days. The total/all-cause mortality was 6% (n=2). The mortality due to COVID-19 infection was 3% (n=1). Subsequently, 89% were restarted on systemic therapy. The median delay in restarting systemic therapy was 23 days. Conclusion: Systemic therapy can be safely administered during the ongoing COVID19 pandemic. Further, follow-up of patients is warranted to assess the long-term impact of COVID-19 infection. Indhuja Muthiah VaikundarajaManikandan DhanushkodiVenkatraman RadhakrishnanJayachandran Peumal KalaiyarasiGangothri SelvarajanSiva Sree KesanaCarthikeyan SMPriya IyerBalasubramanian AnanthiArvind KrishnamurthySridevi VelusamyTenali Gnana SagarKaviani Breast Disease InstitutearticleBreast cancerCOVID-19 infectionOutcomeNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENArchives of Breast Cancer (2021)
institution DOAJ
collection DOAJ
language EN
topic Breast cancer
COVID-19 infection
Outcome
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Breast cancer
COVID-19 infection
Outcome
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Indhuja Muthiah Vaikundaraja
Manikandan Dhanushkodi
Venkatraman Radhakrishnan
Jayachandran Peumal Kalaiyarasi
Gangothri Selvarajan
Siva Sree Kesana
Carthikeyan SM
Priya Iyer
Balasubramanian Ananthi
Arvind Krishnamurthy
Sridevi Velusamy
Tenali Gnana Sagar
Outcome of Breast Cancer Patients with COVID-19 Infection: A Report from a Tertiary Cancer Center in India
description Background: There is no data on the outcome of COVID-19 infection in patients with breast cancer from India. This study was done to assess the outcome of patients with breast cancer who had COVID-19 infection. Methods: We analyzed patients with breast cancer who were diagnosed with COVID-19 infection from May to September 2020 in the medical oncology department of a tertiary cancer center in India. Symptomatic patients (fever and influenza-like illness symptoms) or asymptomatic patients planned for systemic therapy were tested for COVID-19 by RT-PCR. Results: A total of 441 breast cancer patients received 1174 systemic therapies from May to September 2020. Among them, 36 patients who had COVID-19 infection were analyzed in detail. The majority (86%) were asymptomatic at presentation. The most common symptoms were fever followed by cough. Patients were either admitted to the hospital (53%) or kept in home quarantine (47%). Patients who received oxygen, non-invasive assisted ventilation (NIV), and mechanical ventilation (MV) were 8%, 3%, and 3% respectively. The median duration of hospitalization and home quarantine was 11 days and 19 days respectively. The recovery of patients with COVID-19 infection was 94%. The median duration to clearing SARS-COV-2 by RT-PCR was 19 days. The total/all-cause mortality was 6% (n=2). The mortality due to COVID-19 infection was 3% (n=1). Subsequently, 89% were restarted on systemic therapy. The median delay in restarting systemic therapy was 23 days. Conclusion: Systemic therapy can be safely administered during the ongoing COVID19 pandemic. Further, follow-up of patients is warranted to assess the long-term impact of COVID-19 infection.
format article
author Indhuja Muthiah Vaikundaraja
Manikandan Dhanushkodi
Venkatraman Radhakrishnan
Jayachandran Peumal Kalaiyarasi
Gangothri Selvarajan
Siva Sree Kesana
Carthikeyan SM
Priya Iyer
Balasubramanian Ananthi
Arvind Krishnamurthy
Sridevi Velusamy
Tenali Gnana Sagar
author_facet Indhuja Muthiah Vaikundaraja
Manikandan Dhanushkodi
Venkatraman Radhakrishnan
Jayachandran Peumal Kalaiyarasi
Gangothri Selvarajan
Siva Sree Kesana
Carthikeyan SM
Priya Iyer
Balasubramanian Ananthi
Arvind Krishnamurthy
Sridevi Velusamy
Tenali Gnana Sagar
author_sort Indhuja Muthiah Vaikundaraja
title Outcome of Breast Cancer Patients with COVID-19 Infection: A Report from a Tertiary Cancer Center in India
title_short Outcome of Breast Cancer Patients with COVID-19 Infection: A Report from a Tertiary Cancer Center in India
title_full Outcome of Breast Cancer Patients with COVID-19 Infection: A Report from a Tertiary Cancer Center in India
title_fullStr Outcome of Breast Cancer Patients with COVID-19 Infection: A Report from a Tertiary Cancer Center in India
title_full_unstemmed Outcome of Breast Cancer Patients with COVID-19 Infection: A Report from a Tertiary Cancer Center in India
title_sort outcome of breast cancer patients with covid-19 infection: a report from a tertiary cancer center in india
publisher Kaviani Breast Disease Institute
publishDate 2021
url https://doaj.org/article/156670456bfc49909bb189f51ad1c0cd
work_keys_str_mv AT indhujamuthiahvaikundaraja outcomeofbreastcancerpatientswithcovid19infectionareportfromatertiarycancercenterinindia
AT manikandandhanushkodi outcomeofbreastcancerpatientswithcovid19infectionareportfromatertiarycancercenterinindia
AT venkatramanradhakrishnan outcomeofbreastcancerpatientswithcovid19infectionareportfromatertiarycancercenterinindia
AT jayachandranpeumalkalaiyarasi outcomeofbreastcancerpatientswithcovid19infectionareportfromatertiarycancercenterinindia
AT gangothriselvarajan outcomeofbreastcancerpatientswithcovid19infectionareportfromatertiarycancercenterinindia
AT sivasreekesana outcomeofbreastcancerpatientswithcovid19infectionareportfromatertiarycancercenterinindia
AT carthikeyansm outcomeofbreastcancerpatientswithcovid19infectionareportfromatertiarycancercenterinindia
AT priyaiyer outcomeofbreastcancerpatientswithcovid19infectionareportfromatertiarycancercenterinindia
AT balasubramanianananthi outcomeofbreastcancerpatientswithcovid19infectionareportfromatertiarycancercenterinindia
AT arvindkrishnamurthy outcomeofbreastcancerpatientswithcovid19infectionareportfromatertiarycancercenterinindia
AT sridevivelusamy outcomeofbreastcancerpatientswithcovid19infectionareportfromatertiarycancercenterinindia
AT tenalignanasagar outcomeofbreastcancerpatientswithcovid19infectionareportfromatertiarycancercenterinindia
_version_ 1718373015406772224